{"id":"https://openalex.org/W4404850802","doi":"https://doi.org/10.1016/j.xphs.2024.11.021","title":"Qualification of mechanistic models in biopharmaceutical process development","display_name":"Qualification of mechanistic models in biopharmaceutical process development","publication_year":2024,"publication_date":"2024-11-29","ids":{"openalex":"https://openalex.org/W4404850802","doi":"https://doi.org/10.1016/j.xphs.2024.11.021","pmid":"https://pubmed.ncbi.nlm.nih.gov/39617055"},"language":"en","primary_location":{"id":"doi:10.1016/j.xphs.2024.11.021","doi":"https://doi.org/10.1016/j.xphs.2024.11.021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.11.021","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.xphs.2024.11.021","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004913197","display_name":"Till Briskot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Till Briskot","raw_affiliation_strings":["Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114882068","display_name":"Dominik Hiltmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Hiltmann","raw_affiliation_strings":["Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019854562","display_name":"Federico Rischawy","orcid":"https://orcid.org/0000-0002-2267-0019","observed_orcids":["https://orcid.org/0000-0002-2267-0019"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Federico Rischawy","raw_affiliation_strings":["Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019556076","display_name":"Joey Studts","orcid":"https://orcid.org/0000-0001-7793-1514","observed_orcids":["https://orcid.org/0000-0001-7793-1514"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Joey Studts","raw_affiliation_strings":["Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041695743","display_name":"Simon Kluters","orcid":"https://orcid.org/0000-0002-3619-6821","observed_orcids":["https://orcid.org/0000-0002-3619-6821"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Simon Kluters","raw_affiliation_strings":["Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany. Electronic address: simon.kluters@boehringer-ingelheim.com","Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany. Electronic address: simon.kluters@boehringer-ingelheim.com"],"raw_orcid":"https://orcid.org/0000-0002-3619-6821","affiliations":[{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Ri\u00df, 88397 Biberach, Germany. Electronic address: simon.kluters@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Ri\u00df, Germany. Electronic address: simon.kluters@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041695743"],"corresponding_institution_ids":["https://openalex.org/I1330995197"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":{"value":3620,"currency":"USD","value_usd":3620},"fwci":0.6672,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.59916993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"114","issue":"2","first_page":"1095","last_page":"1107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.63919997215271,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.63919997215271,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.04529999941587448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11053","display_name":"Process Optimization and Integration","score":0.03970000147819519,"subfield":{"id":"https://openalex.org/subfields/2207","display_name":"Control and Systems Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mechanistic-process-model","display_name":"mechanistic process model","score":0.8939999938011169},{"id":"https://openalex.org/keywords/model-qualification","display_name":"model qualification","score":0.9819999933242798},{"id":"https://openalex.org/keywords/biopharmaceutical-process-development","display_name":"biopharmaceutical process development","score":0.9449999928474426},{"id":"https://openalex.org/keywords/regulatory-guidance","display_name":"regulatory guidelines","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.8761340379714966},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.6251871585845947},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.5967035293579102},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5778515338897705},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.552047073841095},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3610243797302246},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3468806743621826},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33609631657600403},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.23860597610473633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21598991751670837},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.19016703963279724},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.15837544202804565},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13952341675758362},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13447225093841553},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.13278543949127197},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001702","descriptor_name":"Biopharmaceutics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D014462","descriptor_name":"Ultrafiltration","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.xphs.2024.11.021","doi":"https://doi.org/10.1016/j.xphs.2024.11.021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.11.021","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:39617055","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39617055","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.xphs.2024.11.021","doi":"https://doi.org/10.1016/j.xphs.2024.11.021","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.11.021","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W100464641","https://openalex.org/W1986235017","https://openalex.org/W2047389923","https://openalex.org/W2079604837","https://openalex.org/W2106962049","https://openalex.org/W2119770416","https://openalex.org/W2146789211","https://openalex.org/W2176564148","https://openalex.org/W2185640829","https://openalex.org/W2255465777","https://openalex.org/W2480937959","https://openalex.org/W2584645514","https://openalex.org/W2585413710","https://openalex.org/W2747543741","https://openalex.org/W2953513972","https://openalex.org/W2965872925","https://openalex.org/W2968060382","https://openalex.org/W2981556959","https://openalex.org/W3001465925","https://openalex.org/W3045993773","https://openalex.org/W3085705141","https://openalex.org/W3168038426","https://openalex.org/W3178070822","https://openalex.org/W3183143843","https://openalex.org/W3186443472","https://openalex.org/W3201586713","https://openalex.org/W4211045448","https://openalex.org/W4221033952","https://openalex.org/W4254133095","https://openalex.org/W4310787331","https://openalex.org/W4376638605","https://openalex.org/W4401418803","https://openalex.org/W4401436913","https://openalex.org/W4401514490","https://openalex.org/W6927086643"],"related_works":["https://openalex.org/W2338713484","https://openalex.org/W2460875677","https://openalex.org/W4409563586","https://openalex.org/W6908778464","https://openalex.org/W2255465777","https://openalex.org/W2768809684","https://openalex.org/W7203791136","https://openalex.org/W3158833935","https://openalex.org/W4401436913","https://openalex.org/W7049026315"],"abstract_inverted_index":{"Mechanistic":[0],"process":[1,10,16,21,57,73,107,143,171,196],"models":[2,70,108,193],"play":[3],"an":[4,186],"increasingly":[5],"important":[6],"role":[7],"in":[8,14,56,71,106,169,194],"biopharmaceutical":[9,72,139,170,195],"development":[11,74],"and":[12,19,64,86,103,141,144,164,184],"manufacturing":[13],"supporting":[15],"design,":[17],"characterization,":[18],"informing":[20],"control":[22,147],"strategies.":[23],"Despite":[24],"the":[25,43,90,96,116,124,175,182,189],"potential":[26],"of":[27,45,99,115,123,137,149,191],"mechanistic":[28,69,192],"models,":[29],"there":[30],"is":[31,50,75],"currently":[32],"no":[33],"clear":[34],"consensus":[35],"or":[36],"regulatory":[37],"guideline":[38],"on":[39,188],"their":[40],"qualification,":[41],"i.e.":[42],"processes":[44],"determining":[46],"whether":[47],"a":[48,62,134,138,145,150,160],"model":[49],"suitable":[51],"to":[52,177],"support":[53],"decision":[54],"making":[55],"development.":[58,172,197],"In":[59],"this":[60],"work,":[61],"systematic":[63],"risk-based":[65],"qualification":[66,190],"framework":[67,78,126,156],"for":[68,162,166],"introduced.":[76],"The":[77,154],"integrates":[79],"key":[80],"concepts":[81,122],"from":[82],"other":[83,167],"modeling":[84,179],"frameworks":[85],"guidelines":[87],"such":[88],"as":[89,159],"ASME":[91],"V&V":[92],"40":[93],"published":[94,109],"by":[95,110],"American":[97],"Society":[98],"Mechanical":[100],"Engineers":[101],"(ASME)":[102],"preliminary":[104],"considerations":[105],"Quality":[111],"Innovation":[112],"Group":[113],"(QIG)":[114],"European":[117],"Medicines":[118],"Agency":[119],"(EMA).":[120],"Key":[121],"proposed":[125],"are":[127],"discussed":[128],"using":[129],"two":[130],"case":[131],"studies,":[132],"including":[133],"model-informed":[135,146],"optimization":[136],"ultrafiltration":[140],"diafiltration":[142],"strategy":[148],"chromatography":[151],"polishing":[152],"step.":[153],"suggested":[155],"can":[157],"act":[158],"foundation":[161],"dialogue":[163],"guide":[165],"modelers":[168],"It":[173],"holds":[174],"capability":[176],"harmonize":[178],"procedures":[180],"throughout":[181],"industry":[183],"establish":[185],"agreement":[187]},"counts_by_year":[{"year":2026,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-11-30T00:00:00"}